One influential parameter which mediates interactions between many types of molecules and biological membranes stems from the lumped contributions of the transmembrane potential, dipole potential and the difference in the surface potentials on both sides of a membrane. With relevance to cell physiology, such electrical features of a biomembrane are prone to undergoing changes as a result of interactions with the aqueous surrounding. Among the most useful tools devoted to exploring changes of electrical parameters of a lipid membrane induced by certain extracellular ions, lipid composition, and embedded membrane peptides and proteins, are spectroscopic imaging and the inner field compensation (IFC) method. In this work we layout the principles of a fully computerized version of the IFC method, which makes it more readily available to users. As a direct application, we deployed this improved version of the IFC method to timeresolve changes induced by alamethicin monomers upon membrane dipole potential, following their aggregation within an artificial lipid membrane. Intriguingly, even prior crossing the membrane core, the membrane-bound alamethicin monomers are shown to significantly increase the dipole potential of the monolayer they reside in. Such data further emphasize the yet less-explored interplay between membrane-based protein and peptides, and the membrane dipole potential.
Introduction
The core architectural design of all biological membranes is a double layer of lipids which acts as a energy barrier against diffusion of polar molecules and ions. Most membrane lipids fall into the class of phospholipids possessing two hydrophobic chains made up of the -CH 2 -and -CH 3 -groups of the fatty acyl chains, and various charged or neutral hydrophilic headgroups [1] .
Generally speaking, the overall electrical profile of a biomembrane consists of contributions from the transmembrane potential, dipole potential and the difference in the surface potentials on both sides of a membrane [2, 3] . While the transmembrane potential results from a charge gradient across the membrane and the surface potential from the net excess charge present at the membrane surface, the membrane dipole potential has its origin in the molecular dipoles located on the lipid molecules. Structural studies on biomembranes have revealed that two main factors underline the origin of the dipole potential: the orientation of dipolar groups located on the lipid molecule, (i.e., the dipole of the carbonyl group of the ester bond and the P − -N + dipole of the head group), and the dipoles of oriented water molecules at the membrane-water interface [4] [5] [6] . Its overall value (∼ 300 mV, positive toward the membrane interior) and the ensuing extremely high electric field associated with it over the aqueous phase -hydrocarbon region interface (10 8 − 10 9 V m −1 ), endow the dipole potential with major roles in the modulation of molecular processes which take place within a biomembrane. The dipole potential has been shown to play an important role for proteins insertion and functioning [7] , kinetics of the gramicidin channel (8) , modulation of the activity of phospholipase A2 [9] and electrical conductance of certain aqueous protein pores [10] . Moreover, dipole potential was shown to affect the membrane insertion and folding of a model amphiphilic peptide [11] , as well as the extent of the membrane fusion [12] . More interestingly, studies undertaken on peptides and proteins embedded on membranes with various compositions illustrated the interplay between the structure, dynamics, and function of such macromolecules and the properties of the lipid membrane. In the simplest terms and from an electrical perspective, a membrane-inserted peptide or protein may modulate the dipole potential of the membrane by affecting the hydration layer of the interface and/or by causing small variations in the orientation of the P − -N + dipole. With respect to this last effect, it should be noted that even small alterations in the geometrical orientation of the P − -N + dipole caused by the embedded protein or peptide, would lead to an increase in the probability of its orientations perpendicular to the interfacial plane, and induce an augmented dipole potential change in a direction normal to the membrane plane. In this line of argument and to name just a few, there are a number of studies which specifically demonstrate that, for instance, melittin is able to modify the orientation of the P − -N + dipole [13, 14] . Molecular dynamics studies on a pore-forming pentameric bundle of α-helical polypeptides embedded on a DMPC lipid bilayer, demonstrated that among the main effects exerted by such a model peptide, a more disordered distribution of the lipid headgroup dipole moments at the membrane interface -which become mostly oriented toward the aqueous phase of the membrane -is present [15] . One of the powerful methods to time-resolve and characterize experimentally the effects induced by peptides and proteins insertion upon the dipole potential component of lipid membranes, is called the inner field compensation method (IFC), and it makes use of the well-known dependence of the membrane capacitance upon the effective potential difference applied. Due to its extensive presentation in literature since early 1970s [16] [17] [18] [19] [20] , we will remind only that within the assumptions of electrostriction effects on an equivalent 'elastic' capacitor or change in the membrane area caused by an increase in the amplitude of thermal fluctuations, the dependence of the membrane capacitance upon the applied voltage (U) is given by a quadratic function (C = C 0 (1 + αU 2 )). In this expression, C 0 stands for the minimum value of the membrane capacitance and α [V −2 ] is a parameter specific for each individual membrane. For the case of neutral lipids, the net voltage drop sensed by the membrane core results from the externally applied potential difference and the difference in the dipole potentials of the two monolayers (Δp) which make up the lipid membrane. Therefore, the membrane capacitance will assume its minimum value (C 0 ) when the externally applied potential difference compensates for the difference in the dipole potential, thus entailing a net zero value for the potential difference across the hydrophobic core of the lipid membrane (i.e., U = 0). One efficient protocol to quantify the difference in the dipole potential from the two monolayers of a lipid membrane is to subject the membrane to a sinusoidal time-varying potential difference superimposed on a dc bias (U = U 0 + U 1 sin (2πυt)). Taking into account the non-linear behavior of the membrane with respect to the applied potential difference, it can be easily demonstrated that the resulting capacitive current through the membrane in response to the potential difference (U) which adds up over the difference in the dipole potential (Δp), consists of three equally spaced harmonic components (i.e., ν, 2ν and 3ν). With direct relevance to the implementation of the IFC method, the amplitude of the second harmonic component from the capacitive current described above is: I 2 = 3αC 0 (U 1 ) 2 (U 0 + Δp) (2πυ) sin (4πυt). Therefore, by continuously varying in the right sense the dc bias (U 0 ) of the applied potential difference, one would soon arrive at the situation when (U 0 + Δp) = 0, which in turn leads to a vanishingly null value of I 2 . At this point, it is safe to assume that the difference in the dipole potential (Δp) of the studied lipid membrane equals (-U 0 ). Among many others, the practical deployment of the IFC methods requires one essential piece of equipment, namely a lock-in amplifier set to detect and record the amplitude of the second harmonic described above, and eventually assist with the canceling step of this current component.
Herein, we present a completely automated implementation of the IFC method, which may prove easier to implement and operate. The core design of the presented IFC method lies in the use of an A/D -D/A acquisition board operated via a graphical programming language, to monitor the time-evolution of the second harmonic component from the capacitive current generated through a lipid membrane. In addition, the same piece of equipment is being used to iteratively feed in controllable dc voltage biases, which will eventually compensate for the difference in the dipole potential (Δp) of the studied lipid membrane.
We further employed our system to monitor in real time changes induced by alamethicin monomers upon membrane dipole potential, following their aggregation within an artificial lipid membrane. We noted that under conditions which preclude alamethicin crossing the membrane core, thus leaving the membrane conductance rather low (i.e., zero applied potential difference), the membrane-bound alamethicin monomers significantly increase the dipole potential of the monolayer they initially reside in. Such data further emphasize the yet less-explored interplay between membrane-based protein and peptides, and the membrane dipole potential.
Materials and methods
The artificial folded bilayer membranes and current recordings were carried out as previously described (21) . Briefly, a 25-μm thick Teflon septum was clamped between two Teflon chambers each of 1 ml volume, containing 1 M NaCl, pH 7.3. A bilayer was formed on an aperture of 100-μm diameter in the septum that had been pre-treated with 10% (v/v) hexadecane (Sigma-Aldrich) in highly purified n-pentane (Sigma-Aldrich). The lipid used was L-α-phosphatidylcholine (Sigma-Aldrich) dissolved in n-pentane 1% (w/v). Currents from the bilayer chamber obtained in response to voltage stimuli were detected and amplified with an integrating headstage Axopatch 200 B amplifier (Molecular Devices, USA) set on the voltage-clamp mode, and all experiments were performed at a room temperature of ∼ 25
• C.
To implement the automated-version of the IFC method, we employed an A/D -D/A NI PCI 6014, 16 bit acquisition board (National Instruments, Inc., USA). The simultaneous A/D and D/A modus operandi of the PCI card used throughout, along with all-decision making steps, spectral analysis and data handling, have been implemented with the help of the LabView graphical programming language (National Instruments, Inc., USA) within the 'virtual-instrument' concept [22] . The mostly-capacitive current through the lipid bilayer which results in response to the applied voltage signal, was collected via Ag/AgCl electrodes, amplified and low-pass filtered (2 kHz cutoff frequency, Bessel filter) with the help of the integrating head-stage amplifier. The resulting signal was fed into an A/D channel of the PCI card and sampled at a rate of 5 kHz under the control of a PC-compatible 2.13 GHz, Intel Celeron computer. In order to perform a preliminary check of the devised system, we monitored the exogenous-induced changes in the difference of the dipole potential (Δp) of a symmetrical lipid membrane. For this, we used phlorizin, a compound which alters the membrane dipole potential only on the side of the membrane it has been added to [10] . In such experiments, the electrolyte contained in addition phosphate buffer (10 mM), and the pH value of the solution measured with a Hanna 211R digital pH meter (Hanna Instruments, USA) and set to a 4.7 value. When used, alamethicin monomers (Sigma-Aldrich) were added from a stock solution made in ethanol, in the cis chamber only, connected to the ground. In order to maintain a low value for the ohmic conductance of the membrane, so that the IFC evaluations would not be disturbed [18] , experiments with alamethicin were performed under conditions which preclude its crossing over the membrane core, thus leaving the membrane conductance rather low (i.e., zero applied potential difference).
Results
The working principle of the method used for the automated real-time monitoring of the difference in the dipole potential (Δp) of a lipid membrane is described in Fig. 1 . The dc biased, sinusoidal time-varying potential difference (U = U 0 + U 1 sin (2πυt), ν = 220 Hz, U 1 = 60 mV) was applied to the lipid membrane from the output of a D/A channel of the PCI card. To reach across the membrane, this voltage signal was fed into an external command input from the integrating head-stage amplifier. Following a real-time spectral analysis, three equally spaced harmonic components (i.e., ν, 2ν and 3ν) show up into the power-spectrum of the electrical current recorded.
Depending on the amplitude of the second harmonic component, a decision-making programming code will add up to (or subtract from) the initial dc bias (U 0 ) incremental values, as to continuously lower the amplitude of the second harmonic component contained in the resulting electrical current through the membrane. As soon as the amplitude of this harmonic drops below a specified value (A(4πν) ≤ δ Fig. 1 ), the decision-making code will bring the whole sequence of iterations described above to a halt, and the last value of the dc bias written at the output of the D/A channel will represent the difference in the dipole potential (Δp) of the membrane.
Alternatively, to only monitor how the difference in the dipole potential (Δp) of the membrane unfolds in time as a result of specific interactions, the dc bias of the applied voltage signal is kept constant (usually zero, for symmetrical phosphatidylcholine-based membranes) and the time-evolution of the amplitude of the second harmonic component is recorded.
The method used for the automated real-time monitoring of the difference in the dipole potential (Δp) of the membrane was firstly put to test on a lipid membrane interacting with phlorizin. This structural analogs of phloretin is known to decrease the intrinsic dipole moments of the lipid monolayer they get adsorbed to; apparently, this phenomenon is favoured by an antiparallel alignment of phlorizin dipole moments relative to the intrinsic dipolar groups of the membrane [23] . We reasoned that monitoring the unfolding of the interaction between phlorizin and lipid membranes, as seen from prospective changes of the difference in the dipole potential (Δp) of the membrane, would provide us with an excellent control of the method we implemented.
In Fig. 2 we present real-time changes of the (Δp) component caused by the addition of 500 μM phlorizin in the cis side of the artificial membrane, connected to the ground. That is, by maintaining a zero value for the dc bias of the applied potential difference across the membrane (U = U 0 + U 1 sin (2πυt), ν = 220 Hz, U 1 = 60 mV, U 0 = 0 mV), we monitored the amplitude of the second harmonic component from the resulting capacitive current across the membrane. Under the above-mentioned conditions, the most likely cause for a time-alteration in the amplitude of this component is a continuous change of the difference in the dipole potential (Δp) of the membrane; this in turn reflects the time-dependent adsorption kinetics of phlorizin to the cis side of the lipid membrane. The time resolution of our measurements (∼ 1.2 sec) was limited only by the CPU speed of the computer used to run and control the virtual instrument used for the automated real-time monitoring of the difference in the dipole potential of the membrane.
We next turned attention to a yet less-explored paradigm of the existing interplay between membrane-based protein and peptides, and the membrane dipole potential. For this, we made an attempt to monitor quantitatively the extent to which alamethicin monomers alter the (Δp) of the membrane. When added to one side of a membrane, alamethicin monomers get inserted into it and under optimal conditions (i.e. positive electrical potential on the side of their addition) generate highly voltage-dependent pores. In the absence of an applied potential difference, the disordered form of the aqueous dissolved alamethicin reaches an equilibrium with the membrane-bound form of it; in this last state, alamethicin becomes mostly helical with its N-terminal part slightly buried in the hydrophobic core and tilted with an average angle of ∼30
• with respect to the bilayer plane. Taken into account the rather large dipole moment of alamethicin monomers of about 40 -80 D [24] , we argued that it is very likely for the dipole moment of the lipid monolayer where alamethicin inserts to undergo time-dependent changes, which would reflect alamethicin partitioning from the aqueous phase into the monolayer. Based on the same rationale as presented above, data presented in Fig. 3 , panel a, show that shortly upon alamethicin addition to the cis side of the lipid membrane, the amplitude of the dipole potential of the cis lipid monolayer changes continuously, with a rather slow time constant. As emphasized before, the observed phenomenon reflects the partial partitioning of alamethicin monomers within the membrane. However, as opposed to real-time changes of the (Δp) component caused by the addition of 500 μM phlorizin (Fig. 2, panel a) , the kinetics of (Δp) changes caused by the partitioning of alamethicin monomers within the membrane does not seem to follow a simple exponential-like course. Although a thorough investigation is needed to fully elucidate this phenomenon, one may propose at this point that this is a reflection of a wide range of values of the interfacial orientations adopted by alamethicin within the cis lipid monolayer. In turn, this would translate into a continuous range of changes of the dipole moment of the cis monolayer caused by the interfacial alamethicin monomers. Additional arguments that can be employed to rationalize the departure of the kinetics shown in Fig. 3 , panel a, from a simple mono-exponential-like curve stem from the fact that even in the absence of the potential difference across the lipid membrane, the alamethicin peptide adopts two kinds of orientations: a tilted orientation at the membrane-aqueous solution interface, and a more fully transmembrane-inserted orientation, with the N terminal almost reaching to the trans side of the membrane [25, 26] . Although the alamethicin monomers in this latter orientation are very unlikely to attain the 'critical concentration' needed generate transmembrane conductive oligomers, they may also contribute to the overall changes of the dipole potential (Δp) of the membrane. To quantify the change of the dipole moment of the cis monolayer, we allowed for small incremental changes (5 mV on each step) of the dc component from the applied potential difference signal. From Fig. 3, panel b, it is seen that ∼ 85 mV positive on the trans side of the lipid membrane lead to an almost complete canceling of the amplitude of the second harmonic component from the capacitive current across the membrane. By simple analysis, this in turn points to the fact that the partial embedment of alamethicin monomers into the cis lipid monolayer increase the dipole moment of it. If incremental changes of the dc component were made in the negative range of potentials, the cancel-out effect of the amplitude of the second harmonic component was un-attainable and the peak of this component became further heightened (data not shown).
Discussion
Based on the 'virtual instrumentation' concept, we succeeded in implementing a completely automated implementation of the IFC method. The core design of this IFC method lies in the use of an A/D -D/A acquisition board operated via a graphical programming language, to monitor the time-evolution of the second harmonic component from the capacitive current generated through a lipid membrane. Without the use of usually employed lock-in amplifiers, the major advantage of our computerized version of the IFC method lies in its cost-effectiveness and portability, which makes it more readily available to users. Although in our system the time resolution of measurements (∼ 1.2 sec) was limited only by the CPU speed of the computer used to run and control the described virtual instrument, faster computers would definitely bring more speed to this design, making it more prone to follow in real-time faster changes of the membrane dipole potential. As a direct application, we employed our system to time-resolve changes induced by alamethicin monomers upon the dipole potential of a symmetrical lipid membrane, following their aggregation within the cis monolayer. Under conditions that prevent alamethicin hopping the membrane core (i.e., zero applied potential difference), the membrane-bound form of alamethicin monomers were shown to significantly increase the dipole potential of the monolayer they reside in. Once embedded and presumably via long-range dipole-dipole interactions, the helical part of alamethicin monomers may destabilize the geometrical orientation of the P − -N + dipole of phosphatidylcholine lipids and induce an alteration of the lumped dipole moment of that monolayer. Alternatively, alamethicin's intrinsic dipole moment -oriented such that the positive end points towards the inner core of the membrane -may also contribute to the alteration of the dipole potential of the cis lipid monolayer. Such data are useful to the further exploration the interplay between membrane-based protein and peptides, and the membrane dipole potential [7, 15, 27, 28] . To this end, our study brings to attention novel evidence that supports the paradigm of the electrical interplay that exists between membrane peptides and the membrane dipole potential. Our results seem to be in good phenomenological correlation with data gathered recently, via the dual-wavelength ratiometric fluorescence method, that have shown that the addition of gramicidin A to DPPC liposomes leads to a decrease in the fluorescence ratio of RH421 that is similar to the effect of phloretin, which is known to decrease the dipole potential [29] . A reasonable explanation for this phenomenon was based on the assertion that gramicidin reduces the existing positive dipole potential of monolayers and bilayers by inducing reorientation of dipole-carrying groups. Such a possibility has also been brought forward by other previous data, leading to the conclusion that the molecular mechanisms by which the binding of the peptide to the membrane affects the dipole potential, indicates the possible arrangements of membrane dipoles as well as the peptide helical dipole vectors [12] . Further experiments will be needed to elucidate intricacies of electric interactions that manifest between lipid membranes and ion-channel forming peptides, which seem to bi-univocally modulate each other's physical manifestations. As a future venue of exploration, there does exist the practical possibility that by manipulating at will the sign of change and magnitude of the interfacial dipole field, one may modulate the extent of the penetration of ion-channel forming peptides through the lipid membranes, possibly helping to study more consistently the protein-protein interaction within membranes.
